|
|
909 Third Avenue
New York, NY 10022 USA
phone:(212) 421-7850
fax:(212) 750-9152
|
|
| Symbol |
FRX |
| Exchange |
NYSE |
| Founded |
1954 |
| Employees |
|
|
|
| www.frx.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Forest Laboratories is engaged in both branded and generic forms of ethical drug products. |
|
| Management |
| William J. Candee, III, Chairman; Dan L. Goldwasser; Dr. Lester B. Salans |
| |
|
|
|
|
|
|
|
| Keywords |
| pharmaceutical, therapeutic, cardiovascular, spectrum, licensed drugs |
|
|
|
| Description |
|
Forest Laboratories, Inc. develops, manufactures and sells both branded and generic forms of ethical drug products, which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. Forest's products include those internally developed and those acquired from other pharmaceutical companies and integrated into Forest's marketing and distribution systems. |
|
| Products / Services |
Products include Lexapro and Celexa, serotonin reuptake inhibitors for the treatment of major depression; Benicar, an angiotensin receptor blocker for the treatment of hypertension; memantine for the treatment of Alzheimer's disease; lercanidipine for the treatment of hypertension; acamprosate for the treatment of alcohol dependence; dexloxiglumide for the treatment of patients with constipation-prone irritable bowel syndrome; Aerospan, a hydrofluralkane formulation; Tiazac for the treatment of hypertension and angina, and Oxycodone/Ibuprofen combination for the management of pain.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
